FDA authorizes second antiviral pill to treat Covid-19
By Jamie Gumbrecht, Amanda Sealy and Jacqueline Howard, CNN The US Food and Drug Administration on Thursday authorized Merck’s antiviral pill, molnupiravir, to treat Covid-19 “for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including
Continue Reading